Prot #BGE-105-002: A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multi- Center Study to Evaluate the Safety and Efficacy of Azelaprag (BGE-105) to Mitigate Diaphragm and Peripheral Muscle Atrophy in Participants Aged 60 and Older with Acute Resp

Project: Research project

Project Details

StatusActive
Effective start/end date2/21/24 → 2/21/25

Funding

  • BioAge Labs, Inc. (Prot #BGE-105-002)